LOTUSEYENSELotus Eye Hospital and Institute Limited· Healthcare ServicesHighNeutral
Announced Fri, 5 Jun, 2026 · 10:31 IST

Lotus Eye Hospital Q4 FY26 results: quarterly loss despite revenue rise

Pat NegativeExceptional ItemEbitda Margin CompressionResults View source PDFExplain this filing

LOTUSEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+11.8%Reaction day
₹110.00
prior close
₹110.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.0%+11.8% vs market
Hospital peers, median of 25sector+0.2%+11.6% vs sector

On the reaction day the stock moved 11.8 pts more than Nifty Microcap 250 and 11.6 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
-1.3
30m
-0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+11.8-0.0+11.8+0.2+11.6
Next day
+6.4-2.0+8.3-0.7+7.1
2d
+10.9-0.1+11.0+0.0+10.9
3d
+11.8-1.6+13.4-1.6+13.5
4d
+21.2-2.7+23.9-2.7+23.9
5d
+21.8+0.3+21.6-1.7+23.6
1w
+26.1+2.6+23.5-1.7+27.8
15d
+10.5+4.2+6.3+0.0+10.5
1m
+10.5+6.2+4.4+2.7+7.8
2m
+7.5+8.6-1.2+4.8+2.6
3m
-0.9+11.2-12.1+5.1-6.0
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q4 FY26 standalone audited results: revenue from operations rose to Rs 1,360.92 lakh vs Rs 1,151.25 lakh YoY. FY revenue Rs 5,371.41 lakh vs Rs 4,956.25 lakh. Q4 swung to net loss of Rs 31.95 lakh vs profit of Rs 25.23 lakh. FY26 PAT fell to Rs 8.04 lakh (Rs 73.93 lakh). Borrowings of Rs 1,142.97 lakh raised from nil, more than doubling finance costs. Auditor issued unmodified opinion. Internal auditor reappointed for FY27.

Likely market impact

Profit fell sharply despite revenue growth; new borrowings raise finance costs and pressure margins